CDK4 inhibition enhances anti-melanoma effects of BRAF/MEK inhibition

被引：0
|
作者：
Zhang, Yanping
Hsueh, Eddy C.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2345
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Enhancement of anti-melanoma effect of BRAF and MEK inhibition by metformin
    Zhang, Yanping
    Peng, Guangyong
    Hsueh, Eddy C.
    [J]. CANCER RESEARCH, 2015, 75
  • [2] Anti-melanoma effect of CDK inhibitor and its combination strategy with BRAF inhibition
    Xu, Xiaoou
    Yokoyama, Satoru
    Hayakawa, Yoshihiro
    [J]. CANCER SCIENCE, 2018, 109 : 233 - 233
  • [3] Enhanced cytotoxic activity of BRAF, MEK and PI3K inhibition with combination CDK4/6 inhibition in melanoma cells
    Zhang, Yanping
    Peng, Guangyong
    Hsueh, Eddy C.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [4] CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas
    Pita, Jaime M.
    Raspe, Eric
    Coulonval, Katia
    Decaussin-Petrucci, Myriam
    Tarabichi, Maxime
    Dom, Genevieve
    Libert, Frederick
    Craciun, Ligia
    Andry, Guy
    Wicquart, Laurence
    Leteurtre, Emmanuelle
    Tresallet, Christophe
    Marlow, Laura A.
    Copland, John A.
    Durante, Cosimo
    Maenhaut, Carine
    Cavaco, Branca M.
    Dumont, Jacques E.
    Costante, Giuseppe
    Roger, Pierre P.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Treatment of non-V600-mutated BRAF melanoma: A role for combination MEK and CDK4/6 inhibition
    Sosman, Jeffrey A.
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
    Lelliott, Emily J.
    Mangiola, Stefano
    Ramsbottom, Kelly M.
    Zethoven, Magnus
    Lim, Lydia
    Lau, Peter K. H.
    Oliver, Amanda J.
    Martelotto, Luciano G.
    Kirby, Laura
    Martin, Claire
    Patel, Riyaben P.
    Slater, Alison
    Cullinane, Carleen
    Papenfuss, Anthony T.
    Haynes, Nicole M.
    McArthur, Grant A.
    Oliaro, Jane
    Sheppard, Karen E.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02) : 136 - 146
  • [7] BRAF and MEK inhibition in melanoma
    Dossett, Lesly A.
    Kudchadkar, Ragini R.
    Zager, Jonathan S.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 559 - 570
  • [8] Simultaneous Inhibition of MEK and CDK4 Leads to Potent Apoptosis in Human Melanoma Cells
    Li, Jing
    Xu, Meixiang
    Yang, Zhen
    Li, Albert
    Dong, Jianli
    [J]. CANCER INVESTIGATION, 2010, 28 (04) : 350 - 356
  • [9] Treatment of non-V600-mutated BRAF melanoma: A role for combination MEK and CDK4/6 inhibition.
    Sosman, Jeffrey A.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21
  • [10] Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
    Long, G. V.
    Stroyakovskiy, D.
    Gogas, H.
    Levchenko, E.
    de Braud, F.
    Larkin, J.
    Garbe, C.
    Jouary, T.
    Hauschild, A.
    Grob, J. J.
    Sileni, V. Chiarion
    Lebbe, C.
    Mandala, M.
    Millward, M.
    Arance, A.
    Bondarenko, I.
    Haanen, J. B. A. G.
    Hansson, J.
    Utikal, J.
    Ferraresi, V.
    Kovalenko, N.
    Mohr, P.
    Probachai, V.
    Schadendorf, D.
    Nathan, P.
    Robert, C.
    Ribas, A.
    DeMarini, D. J.
    Irani, J. G.
    Casey, M.
    Ouellet, D.
    Martin, A. -M.
    Le, N.
    Patel, K.
    Flaherty, K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1877 - 1888
12345